Vicarious Surgical (NYSE: RBOT) warrants to be withdrawn from NYSE listing

Rhea-AI Filing Summary

Vicarious Surgical Inc. is having its warrants removed from listing and registration on the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. The notification is made on SEC Form 25, with the Exchange certifying it has reasonable grounds to file.

The affected security is described as warrants, with each whole warrant exercisable for 1/30th of a share of Class A common stock at an exercise price of $345.00. The New York Stock Exchange states it has complied with its rules to strike this class of securities, and that the issuer has complied with exchange and SEC requirements for the voluntary withdrawal of this class from listing and registration.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-39384

Issuer:	Vicarious Surgical Inc.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	78 FOURTH AVENUE
	WALTHAM	MASSACHUSETTS	02451
Telephone number:					617-868-1700

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-12-17	By	Anthony Sozzi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Vicarious Surgical Inc. (RBOT) disclose in this Form 25 filing?

The filing states that Vicarious Surgical Inc. is having a class of its securities removed from listing and registration on the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. The notification is made on SEC Form 25 and is certified by the Exchange.

Which Vicarious Surgical (RBOT) security is being removed from NYSE listing?

The affected security is a class of warrants. Each whole warrant is exercisable for 1/30th of a share of Class A common stock at an exercise price of $345.00, according to the description in the filing.

Who is filing the removal of Vicarious Surgical warrants from the NYSE?

The notification is made by the New York Stock Exchange LLC, which certifies that it has reasonable grounds to believe it meets all requirements for filing Form 25 and has caused the notification to be signed by an authorized person, identified as Anthony Sozzi, Analyst, Market Watch.

What regulatory basis is cited for removing Vicarious Surgical (RBOT) warrants from listing?

The filing references Section 12(b) of the Securities Exchange Act of 1934 and related SEC rules, including 17 CFR 240.12d2-2(b) and 17 CFR 240.12d2-2(c). It states that the Exchange has complied with its rules to strike the class from listing and that the issuer has complied with exchange and SEC requirements for voluntary withdrawal.

What are the key terms of the Vicarious Surgical warrants mentioned in the Form 25?

The warrants are described as allowing each whole warrant holder to purchase 1/30th of a share of Class A common stock at an exercise price of $345.00. These are the specific terms provided for the class of securities being removed from NYSE listing and registration.

When was the NYSE Form 25 for Vicarious Surgical warrants signed?

The notification is dated 2025-12-17 in the signature block, where the New York Stock Exchange LLC certifies the filing through an authorized representative.